Who Paid My Doc Search
Menu
Organisation paid for research Program year 2023 Source: CMS Open Payments

Physician Research Collaboration, LLC

Neither a doctor nor a teaching hospital

Research payments

$190,385

12 payments

Through program year 2023, Physician Research Collaboration, LLC is reported as receiving $190,385 in research payments, across 12 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $15 1
2022 Research $132,084 5
2021 Research $14,504 4
2020 Research $43,752 1
2019 Research $30 1

Breakdown

Who paid Research payments · program years 2019–2023
  1. Navidea Biopharmaceuticals, Inc. $146,206 6 payments
  2. E.R. Squibb & Sons, L.L.C. $43,981 5 payments
  3. Sun Pharmaceutical Industries Inc. $198 1 payment
Studies the money was for Research payments · program years 2019–2023
  1. Evaluation of Tc 99m Tilmanocept Imaging for the Early Prediction of Anti-TNF-alpha Therapy Response in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA) $131,860 3 payments
  2. A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Branebrutinib Treatment in Subjects With Active Systemic Lupus Erythematosus or Primary Sjgren's Syndrome, or Branebrutinib Treatment Followed by Open- $43,752 1 payment
  3. Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value on Tc 99m Tilmanocept Planar Imaging $14,346 3 payments
  4. INSPIRE LTE study $198 1 payment
  5. AMPLIFIED Study $158 1 payment
  6. Phase 2A 2B RA $30 1 payment
  7. AMPLIFIED - A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Cl $26 1 payment
  8. MAD in Patients/Phase 1B (Lupus) - A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986326 in Adult Participants with Discoid Lupus $15 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record